2023 PatientsForce Patient Assistance Services Report
AI-translated from the Chinese original · editorially reviewed
PatientsForce: Expert Solutions for Patients' Treatment Challenges
The PatientsForce team is committed to designing comprehensive service programs that help patients ease their treatment burden and complete their prescribed treatment course. Working hand in hand with a professional consulting and management team and international pharmaceutical companies, we integrate social resources, run patient assistance programs, and provide health education and counseling services — putting patients at the center to shorten the path to medical access and accompany patients through their treatment journey.
The top choice for Top 10 global pharmaceutical companies running patient support programs
The PatientsForce team partners with nearly 30 pharmaceutical companies. According to the list of the world's top 50 pharmaceutical companies published by Pharmaceutical Executive (a U.S. pharmaceutical management magazine) in June 2023, 60% of the top 10 pharmaceutical companies have chosen to partner with the PatientsForce team to provide patient support program services.
More than 60 drug support programs delivered — covering over 10 disease areas
As of 2023, the patient service programs PatientsForce has carried out cover more than 60 drugs, spanning cancer medications, rare diseases, genetic diseases, chronic diseases, and more — serving more than 10 disease areas. Cancer treatment drugs make up the largest share; based on the site classification of the Ministry of Health and Welfare's cancer registry, PatientsForce's patient support programs cover 65% of cancer sites, spanning more than 15 cancer types.
PatientsForce drug count share by disease type (as of 2023/12/22)
PatientsForce drug count share by cancer type (as of 2023/12/22)
2023 PatientsForce patient assistance results
PatientsForce has cumulatively helped nearly 40,000 patients, with an average of more than 10,000 new patients added each year over the past three years, and patients receive more than one care contact per month on average. PatientsForce's 2023 statistics show that patients receiving supportive care achieved an average medication adherence rate of 95%; the value of assistance disbursed in 2023 exceeded NT$1.4 billion, with each patient receiving assistance obtaining close to NT$200,000 in drug cost support on average. PatientsForce's electronic application and management process lets patients submit application materials via mobile phone, and drug management staff can also complete the patient medication pickup sign-off process online — in 2023, electronic applications accounted for 91% of the year's total application volume, greatly improving the convenience of applying.
PatientsForce 2023 statistics (as of 2023/12/22)
Wen-I Sun, Data Science Business Manager, Media-WIND Health Strategies
weni.sun@media-wind.com.tw